Pluri Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Pluri Inc. (PLUR) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 296.40 thousand shares as of 2023-12-31, per its 10-Q filed 2024-02-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2024-02-12
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 296.40K shares.
- 2023-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 470.69K shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.66M shares.
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.83M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2023-12-31 | 296.40K shares 10-Q · filed 2024-02-12 | |
| 2023-09-30 | 470.69K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 1.66M shares 10-Q · filed 2024-02-12 | |
| 2023-03-31 | 1.83M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 2.02M shares 10-Q · filed 2024-02-12 | |
| 2022-09-30 | 1.80M shares 10-Q · filed 2023-11-13 | |
| 2022-06-30 | 1.94M shares 10-Q · filed 2024-02-12 | 41.25K shares 10-K · filed 2022-09-21 |
| 2022-03-31 | 2.09M shares 10-Q · filed 2023-05-09 | |
| 2021-06-30 | 2.40M shares 10-K · filed 2023-09-12 | 76.25K shares 10-K · filed 2022-09-21 |
| 2020-06-30 | 6.25K shares 10-K · filed 2022-09-21 | |
| 2018-06-30 | 6.49M shares 10-K · filed 2018-09-12 | |
| 2017-06-30 | 6.11M shares 10-K · filed 2017-09-07 | |
| 2016-06-30 | 1.93M shares 10-K · filed 2016-09-07 | |
| 2015-06-30 | 1.76M shares 10-K · filed 2015-09-09 | |
| 2013-06-30 | 1.66M shares 10-K · filed 2013-09-11 | |
| 2012-06-30 | 2.15M shares 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |